https://orcid.org/0000-0003-1285-7602
Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Diana R Tamondong-Lachica, Neil Skolnik, John R Hurst, Nathaniel Marchetti, Adrian Paul J Rabe, Maria Montes de Oca & Bartolome R Celli. (2023) GOLD 2023 Update: Implications for Clinical Practice. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 745-754.
Read now
Read now
Marc Miravitlles, Fernando González-Torralba, Cristina Represas-Represas, Xavier Pomares, Eduardo Márquez-Martín, Cruz González, Carlos Amado, Carles Forné, Soledad Alonso, Bernardino Alcázar, Miriam Barrecheguren, Juan María Jurado Mirete & Elsa Naval. (2022) Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1577-1587.
Read now
Read now
Mario Cazzola, Josuel Ora, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2022) Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?. Expert Opinion on Pharmacotherapy 23:8, pages 917-927.
Read now
Read now
Leah B Sansbury, Chanchal Bains, David A Lipson, Afisi S Ismaila & Sarah H Landis. (2021) Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1255-1264.
Read now
Read now
Articles from other publishers (6)
Hannah R. WhittakerKevin Wing, Ian Douglas, Steven J. Kiddle & Jennifer K. Quint. (2022) Inhaled Corticosteroid Withdrawal and Change in Lung Function in Primary Care Patients with Chronic Obstructive Pulmonary Disease in England. Annals of the American Thoracic Society 19:11, pages 1834-1841.
Crossref
Crossref
X. Flor-Escriche, A. Sanz Bas, S. Álvarez Álvarez, V. Zamora Putin & M. Monteagudo Zaragoza. (2022) Riesgos, fenotipos y comparación de tratamiento de EPOC en atención primaria según guías GOLD y GesEPOC. Medicina de Familia. SEMERGEN 48:8, pages 101839.
Crossref
Crossref
Claudia Cabrera, Céline Quélen, Mario Ouwens, Katarina Hedman, Una Rigney & Jennifer K. Quint. (2022) Evaluating a Cox marginal structural model to assess the comparative effectiveness of inhaled corticosteroids versus no inhaled corticosteroid treatment in chronic obstructive pulmonary disease. Annals of Epidemiology 67, pages 19-28.
Crossref
Crossref
Chloe I. Bloom, Jukka Montonen, Olaf Jöns, Elizabeth M. Garry & Surya P. Bhatt. (2022) Treatment Transitions in Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases. Pulmonary Therapy 8:1, pages 75-93.
Crossref
Crossref
Helgo Magnussen, Sarah Lucas, Therese Lapperre, Jennifer K. Quint, Ronald J. Dandurand, Nicolas Roche, Alberto Papi, David Price & Marc Miravitlles. (2021) Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study. Respiratory Research 22:1.
Crossref
Crossref
Nicolas Roche, Philippe Devillier, Patrick Berger, Arnaud Bourdin, Daniel Dusser, Jean-François Muir, Yan Martinat, Philippe Terrioux & Bruno Housset. (2021) Individual trajectory-based care for COPD: getting closer, but not there yet. ERJ Open Research 7:4, pages 00451-2021.
Crossref
Crossref